Home » Topics » BioWorld Science

BioWorld Science
RSS

Increased clotting contributes to cardiovascular risk in HIV-infected individuals

June 18, 2019

Luspatercept MOA: Up for grabs?

June 18, 2019

Inhibiting CCL24 with CM-101 reduces fibrosis and inflammation in systemic sclerosis

June 18, 2019

Gilead initiates phase I study of GS-1423 in advanced solid tumors

June 18, 2019

LNC helps TNBC go AWOL

June 18, 2019

Telaglenastat doubles PFS in heavily pretreated patients with advanced RCC in ENTRATA trial

June 17, 2019

Antibody-antibiotic conjugate DSTA-4637S well tolerated in phase I study

June 17, 2019

Extracellular vesicles deliver antiaging enzyme

June 17, 2019

Elthera receives funding through E.U.'s Horizon 2020 program

June 17, 2019

TLC reports data from part 1 of phase II bunionectomy trial of TLC-590

June 17, 2019

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...